As MARS42 is approaching, today we are thrilled to present you Giovanni Rizzo, one of the speakers that you will meet during the Summer School.
Dr. Rizzo got his Biology degree at the “La Sapienza” University of Rome, his PhD in Oncology and his specialization in microbiology at the University of Perugia, Italy, his post-graduate qualification in preclinical and clinical development of drugs from University “La Bicocca” Milano and his Master in Business Administration (MBA) at the HULT International Business School, London.
He has extensive experience in drug discovery and development and in medical device development: head of biology of Intercept Pharmaceuticals Inc. and he worked as consultant of Intercept Pharmaceuticals; Consultant of Index Ventures, a venture capital firm; CEO of iDNA Ltd, a drug discovery service company; Vice President of Yaqrit Ltd, a spin off company of the University College London; member of board of directors and chief of the innovation division of ZCube, Zambon group.
He is an entrepreneur and an investor himself of the London Business Angels (LBA) and MedCity Angels, London, and Italian Angels for Biotech, Italy. He has a honorary senior lecturer position at the University College London (UCL) in the Institute of Liver and Digestive Health (ILDH).
During his speech at MARS42 he will share his experience with ZCube - the Zambon Group's Corporate Accelerator - in order to let participants understand how a corporation can leverage on startups to keep innovating and what it takes - as young entrepreneurs in the field of science - to get access to such a great opportunity of collaboration.
MARS42 was made possible thanks to our Main Sponsor Fincantieri.